Mutations in EGFR and KRAS are considered mutually exclusive in NSCLC (26) and this is also remarked by epidemiologic data, being KRAS mutations associated with smoke and EGFR mutations more common in non-smokers, respectively. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.